Jaren Madden

Jaren Madden, Senior Vice President, Investor Relations and Corporate Communications, joined Schrödinger in November 2020. Jaren had previously served as Vice President, Investor Relations and Corporate Communications at Gamida Cell Ltd since August 2018. Jaren brings to Schrödinger over 20 years of experience in biotechnology, investor relations and communications. Before joining Gamida Cell, she served as the global head of research and development communications at Shire Pharmaceuticals, plc. Prior to joining Shire, Jaren led the investor relations and communications team at Infinity Pharmaceuticals, Inc. from 2010 to 2017. She also held communications and investor relations roles of increasing responsibility at Feinstein Kean Healthcare, Alkermes plc and Vertex Pharmaceuticals, Inc. Jaren earned a B.S. in Ecology and Evolutionary Biology and an M.S. in Botany from the University of Connecticut and an M.B.A. from Boston University.